About Stanmore Implants

Stanmore Implants Selects WebOps for US Launch

Stanmore Implants Selects WebOps for US Launch - WebOps Logistics to provide inventory control

May [6], 2013 - ATLANTA, GA (May 6 , 2013) -- Today, WebOps LLC, the leader in medical device field inventory management, announced that Stanmore Implants Worldwide has selected WebOps Logistics as the shared visibility and collaborative workflow platform.

Based on extensive research and internal analysis, Stanmore chose WebOps Logistics to become a strategic partner and key component of its supply chain management system.

Stanmore Implants Worldwide's CEO, Michael Mainelli , said, " We are delighted to be working with WebOps . Ultimately we believe WebOps will allow us to deliver our innovative technologies to our customers as reliably and efficiently as possible."

WebOps' CEO Al Payne said: "We are very excited to be working with Stanmore . We believe our system s will help Stanmore improve sales rep productivity, increase asset utilization, and reduce total supply chain costs."

About WebOps

Now supporting over 50,000 surgeries each month, WebOps helps medical device manufacturers and distributors accurately schedule and manage surgical cases in order to tightly track and control field inventory. WebOps Logistics is a highly mobile, web - based solution used in hospitals, warehouses and other field locations to automate the entire case planning and fulfillment cycle including sales, reverse logistics, replenishment and billing managing over $4 billion in medical device sales to date. Our custo mers enjoy increased sales, reduced inventory, lower freight and courier costs and higher productivity , all while ensuring implant traceability, regulatory compliance and minimized risk. Founded in 2005, WebOps is headquartered in Atlanta, Georgia. Learn more at www.WebOps.com.

About Stanmore

Founded more than 60 years ago in Stanmore, North London, UK, Stanmore Implants Worldwide is one of the global leaders in extreme orthopaedics and is known for creating some of the world's most successful implants . It i s focused entirely on serving the needs of surgeons that treat orthopedic oncology, complex trauma, and complex revisions of primary joint replacement. Stanmore's product portf olio includes both patient specific and off - the - shelf implant systems aimed at limb salvage. Learn more at www.StanmoreImplants.com.